ESC 365 - Assessing variability of response to antiplatelet therapy: is there a role for platelet function and generic testing in clinical practice.

Assessing variability of response to antiplatelet therapy: is there a role for platelet function and generic testing in clinical practice.

Session: Antiplatelet therapy in acute coronary syndromes: translating evidence into clinical practice to improve outcomes

Topic: Antithrombotic agents

Speaker: Doctor P. Gurbel (Baltimore, US)

Organised by The Sahlgrenska Academy - University of Gothenburg / Course Director: Prof. Karl Swedberg / Supported by an unrestricted educational grant from AstraZeneca

Event: ESC Congress 2013

About the speaker

Doctor Paul A Gurbel

Sinai Hospital, Baltimore (United States of America)

0 follower

5 more presentations in this session

Evolving evidence: bridging the gaps among clinical trials, registries, and clinical practice.

Speaker: Professor F. Van de Werf (Leuven, BE)

Access

Slides

Appropriate risk stratification in the management of acute coronary syndromes.

Speaker: Professor A. Budaj (Warsaw, PL)

Access

Slides

Combining antiplatelet and anticoagulant therapy: is more necessarily better?

Speaker: Professor C. Bode (Freiburg im Breisgau, DE)

Access

Slides

Panel and general discussion: antiplatelet therapy in acute coronary syndromes.

Access

Welcome and introduction.

Speaker: Professor C. Granger (Durham, US)

Access

Slides

Access the full session

Antiplatelet therapy in acute coronary syndromes: translating evidence into clinical practice to improve outcomes

Speakers: Doctor P. Gurbel, Professor F. Van de Werf, Professor A. Budaj, Professor C. Bode, Professor C. Granger

Access

About the event

ESC Congress 2013

31 August - 4 September 2013

Sessions Presentations

Assessing variability of response to antiplatelet therapy: is there a role for platelet function and generic testing in clinical practice.

About the speaker

Doctor Paul A Gurbel

5 more presentations in this session

Evolving evidence: bridging the gaps among clinical trials, registries, and clinical practice.

Appropriate risk stratification in the management of acute coronary syndromes.

Combining antiplatelet and anticoagulant therapy: is more necessarily better?

Panel and general discussion: antiplatelet therapy in acute coronary syndromes.

Welcome and introduction.

Access the full session

Antiplatelet therapy in acute coronary syndromes: translating evidence into clinical practice to improve outcomes

About the event

ESC Congress 2013

ESC 365 is supported by